- Home
- CFR vs CORT Comparison
CFR vs CORT Comparison
Compare CFR & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CFR | CORT |
|---|---|---|
| Founded | 1868 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 7.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CFR | CORT |
|---|---|---|
| Price | $128.54 | $82.07 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 6 |
| Target Price | ★ $137.86 | $130.20 |
| AVG Volume (30 Days) | 445.3K | ★ 821.3K |
| Earning Date | 01-29-2026 | 11-04-2025 |
| Dividend Yield | ★ 3.11% | N/A |
| EPS Growth | ★ 20.47 | N/A |
| EPS | ★ 9.72 | 0.87 |
| Revenue | ★ $2,141,575,000.00 | $741,172,000.00 |
| Revenue This Year | $14.17 | $23.79 |
| Revenue Next Year | $4.47 | $40.97 |
| P/E Ratio | ★ $13.24 | $92.87 |
| Revenue Growth | 9.02 | ★ 17.92 |
| 52 Week Low | $100.31 | $49.00 |
| 52 Week High | $146.44 | $117.33 |
Technical Indicators
Market Signals| Indicator | CFR | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 57.76 | 51.62 |
| Support Level | $127.15 | $78.07 |
| Resistance Level | $131.54 | $89.00 |
| Average True Range (ATR) | 2.52 | 3.40 |
| MACD | 0.37 | -0.11 |
| Stochastic Oscillator | 64.95 | 39.42 |
Price Performance
Historical ComparisonAbout CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional US bank with around $50 billion in assets (as of mid-2025), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based approach to banking that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through branch openings. The bank's sweet spot is small to medium-size Texas-based commercial clients.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.